Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?

Endometrial cancer is one of the most common malignant diseases in women worldwide, with an incidence of 5.9%. Thus, it is the most frequent cancer of the female genital tract, with more than 34,000 women dying, in Europe and North America alone. Endometrial Cancer Stem Cells (CSC) might be drivers...

Descripción completa

Detalles Bibliográficos
Autores principales: Banz-Jansen, Constanze, Helweg, Laureen P., Kaltschmidt, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955970/
https://www.ncbi.nlm.nih.gov/pubmed/35328833
http://dx.doi.org/10.3390/ijms23063412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955970/
https://www.ncbi.nlm.nih.gov/pubmed/35328833
http://dx.doi.org/10.3390/ijms23063412

Ejemplares similares